← Back to headlines
Tempus AI to Acquire Cancer-Monitoring Firm Personalis for $1.5 Billion
Tempus AI has announced its acquisition of Personalis, a cancer-monitoring firm, for $1.5 billion. This strategic move aims to expand Tempus AI's growth in MRD (minimal residual disease) testing.
20 Jul, 14:03 — 20 Jul, 16:02
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center1
Center (1)
bloomberg
Right
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Coverage Timeline
First report: bloomberg · 20 Jul, 14:03|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
